Tamiflu
Tamiflu

8.67
For patients managing respiratory conditions, this generic medicine impedes the spread of viral particles to reduce the duration of symptoms and lessen their severity.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Oseltamivir
Reference Brand
Oseltamivir
Product Origin
Generic Alternative
Reference Manufacturer
Roche
Product Form
Capsule
Regulatory Classification
Prescription Only Medicine
Primary Category
Antivirals
Product Category
Neuraminidase Inhibitor
Pharmacological Class
Antiviral
Manufacturer Description
Indicated to address active influenza infections to manage symptom severity and alleviate respiratory illness duration.
Mechanism of Action
Inhibits viral neuraminidase, preventing the release of new viral particles from infected host cells.
Route of Administration
Oral
Onset Time
24–48 hours
Duration
5 days
Contraindications
Severe hypersensitivity to oseltamivir, End-stage renal disease without dialysis
Severe Adverse Events
Severe neuropsychiatric events — requires immediate medical attention, Anaphylaxis — requires immediate medical attention
Common Side Effects
Nausea, Vomiting, Headache
Uncommon Side Effects
Bronchitis, Insomnia, Vertigo
Drug Interactions
Live Attenuated Influenza Vaccine
Pregnancy Safety Warnings
TGA Category C: Deemed generally safe and highly recommended during influenza outbreaks. Breastfeeding: Compatible.
Age Restrictions
Approved for infants over two weeks and adults.
Storage Guidelines
Store below 25°C.
Information related to Tamiflu is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Antipsychotic Medication - Tegretol Price